5-(chloromethyl)-1-methyl-1H-1,2,3,4-tetrazole → HCID 89586171, compound
Reaction equation
C([C:5]1N=C(N2CCC(F)(F)C2)[C:8]2[C:9](=[N:11][N:12](CC)[N:13]=2)[N:10]=1)(C)(C)C.[C:23]([NH:27][C:28]1[N:29]=[C:30]([N:37]2[CH2:41][CH2:40][C@H:39]([OH:42])[CH2:38]2)[C:31]2[N:36]=[N:35][NH:34][C:32]=2[N:33]=1)([CH3:26])([CH3:25])[CH3:24].ClCC1N(C)N=NN=1>>[C:23]([NH:27][C:28]1[N:29]=[C:30]([N:37]2[CH2:41][CH2:40][C@H:39]([OH:42])[CH2:38]2)[C:31]2[C:32](=[N:34][N:35]([CH2:8][C:9]3[N:10]([CH3:5])[N:13]=[N:12][N:11]=3)[N:36]=2)[N:33]=1)([CH3:26])([CH3:24])[CH3:25]Participants
4
Procedure
In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-2-ethyl-2H-[1,2,3]triazolo[4,5-d]pyrimidine (example 3, step b), the title compound was prepared from (S)-1-(5-tert-Butylamino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)-pyrrolidin-3-ol and 5-(chloromethyl)-1-methyl-1H-tetrazole. MS (m/e): 374.3 (MH+).
Sources & evidence
- ORD record
- ord-9d58cd7dc2e8456d96c4320c18dafe6b
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09067943B2
Reaction notes
Loading…